Analyst Ratings for Enanta Pharmaceuticals (ENTA)
ENTA Rating Summary
ENTA Price Target Summary
- Highest: $25.00 (Citizens)
- Lowest: $9.00 (Leerink Partners)
- Average: $19.63
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$19.63 (+44.9%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 82%
Rating Score: 7.8 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/14/2025 | JPMorgan » Updated 3/3/2026 |
Anupam Rama | New Coverage | Overweight (N/A) |
19.00 (17.00) |
11.93 (13.54) |
13.5% | Details |
| 10/1/2025 | Jefferies | Akash Tewari | Upgrade | Buy (Hold) |
20.00 (14.00) |
11.97 (13.54) |
13.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
